Cargando…

Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer

OBJECTIVES: In recent years, a number of structurally diverse Histone deacetylase (HDAC) inhibitors have been identified and these HDAC inhibitors induce growth arrest, differentiation and/or apoptosis of cancer cells in vitro and in vivo. This study aimed at investigating the anti-tumor activity of...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Kyung Nan, Joung, Ki Eun, Kim, Dae-Kee, Sheen, Yhun Yhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Environmental Health and Toxicology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355273/
https://www.ncbi.nlm.nih.gov/pubmed/22639737
http://dx.doi.org/10.5620/eht.2012.27.e2012010
_version_ 1782233348983226368
author Min, Kyung Nan
Joung, Ki Eun
Kim, Dae-Kee
Sheen, Yhun Yhong
author_facet Min, Kyung Nan
Joung, Ki Eun
Kim, Dae-Kee
Sheen, Yhun Yhong
author_sort Min, Kyung Nan
collection PubMed
description OBJECTIVES: In recent years, a number of structurally diverse Histone deacetylase (HDAC) inhibitors have been identified and these HDAC inhibitors induce growth arrest, differentiation and/or apoptosis of cancer cells in vitro and in vivo. This study aimed at investigating the anti-tumor activity of newly synthesized HDAC inhibitor, 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide (IN-2001) using human breast cancer cells. METHODS: We have synthesized a new HDAC inhibitor, IN-2001, and cell proliferation inhibition assay with this chemical in estrogen receptor-positive human breast cancer MCF-7 cells. Cell cycle analysis on MCF-7 cells treated with IN-2001 was carried out by flow cytometry and gene expression was measured by RT-PCR. RESULTS: In MCF-7 cells IN-2001 showed remarkable anti-proliferative effects in a dose- and time-dependent manner. In MCF-7 cells, IN-2001 showed a more potent growth inhibitory effect than that of suberoylanilide hydroxamic acid. These growth inhibitory effects were related to the cell cycle arrest and induction of apoptosis. IN-2001 showed accumulation of cells at G(2)/M phase and of the sub-G(1) population in a time-dependent manner, representing apoptotic cells. IN-2001-mediated cell cycle arrest was associated with HDAC inhibitor-mediated induction of CDK inhibitor expression. In MCF-7 cells, IN-2001 significantly increased p21(WAF1) expression. CONCLUSIONS: In summary, cyclin-dependent kinase (CDK) induced growth inhibition, possibly through modulation of cell cycle and apoptosis regulatory proteins, such as CDK inhibitors, and cyclins. Taken together, these results provide an insight into the utility of HDAC inhibitors as a novel chemotherapeutic regime for hormone-sensitive and insensitive breast cancer.
format Online
Article
Text
id pubmed-3355273
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Korean Society of Environmental Health and Toxicology
record_format MEDLINE/PubMed
spelling pubmed-33552732012-05-25 Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer Min, Kyung Nan Joung, Ki Eun Kim, Dae-Kee Sheen, Yhun Yhong Environ Health Toxicol Original Article OBJECTIVES: In recent years, a number of structurally diverse Histone deacetylase (HDAC) inhibitors have been identified and these HDAC inhibitors induce growth arrest, differentiation and/or apoptosis of cancer cells in vitro and in vivo. This study aimed at investigating the anti-tumor activity of newly synthesized HDAC inhibitor, 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide (IN-2001) using human breast cancer cells. METHODS: We have synthesized a new HDAC inhibitor, IN-2001, and cell proliferation inhibition assay with this chemical in estrogen receptor-positive human breast cancer MCF-7 cells. Cell cycle analysis on MCF-7 cells treated with IN-2001 was carried out by flow cytometry and gene expression was measured by RT-PCR. RESULTS: In MCF-7 cells IN-2001 showed remarkable anti-proliferative effects in a dose- and time-dependent manner. In MCF-7 cells, IN-2001 showed a more potent growth inhibitory effect than that of suberoylanilide hydroxamic acid. These growth inhibitory effects were related to the cell cycle arrest and induction of apoptosis. IN-2001 showed accumulation of cells at G(2)/M phase and of the sub-G(1) population in a time-dependent manner, representing apoptotic cells. IN-2001-mediated cell cycle arrest was associated with HDAC inhibitor-mediated induction of CDK inhibitor expression. In MCF-7 cells, IN-2001 significantly increased p21(WAF1) expression. CONCLUSIONS: In summary, cyclin-dependent kinase (CDK) induced growth inhibition, possibly through modulation of cell cycle and apoptosis regulatory proteins, such as CDK inhibitors, and cyclins. Taken together, these results provide an insight into the utility of HDAC inhibitors as a novel chemotherapeutic regime for hormone-sensitive and insensitive breast cancer. The Korean Society of Environmental Health and Toxicology 2012-04-25 /pmc/articles/PMC3355273/ /pubmed/22639737 http://dx.doi.org/10.5620/eht.2012.27.e2012010 Text en © 2012 The Korean Society of Environmental Health and Toxicology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Min, Kyung Nan
Joung, Ki Eun
Kim, Dae-Kee
Sheen, Yhun Yhong
Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
title Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
title_full Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
title_fullStr Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
title_full_unstemmed Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
title_short Anti-Cancer Effect of 3-(4-dimethylamino phenyl)-N-hydroxy-2-propenamide in MCF-7 Human Breast Cancer
title_sort anti-cancer effect of 3-(4-dimethylamino phenyl)-n-hydroxy-2-propenamide in mcf-7 human breast cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355273/
https://www.ncbi.nlm.nih.gov/pubmed/22639737
http://dx.doi.org/10.5620/eht.2012.27.e2012010
work_keys_str_mv AT minkyungnan anticancereffectof34dimethylaminophenylnhydroxy2propenamideinmcf7humanbreastcancer
AT joungkieun anticancereffectof34dimethylaminophenylnhydroxy2propenamideinmcf7humanbreastcancer
AT kimdaekee anticancereffectof34dimethylaminophenylnhydroxy2propenamideinmcf7humanbreastcancer
AT sheenyhunyhong anticancereffectof34dimethylaminophenylnhydroxy2propenamideinmcf7humanbreastcancer